Brokerages Set Stericycle, Inc. (NASDAQ:SRCL) PT at $59.40

Stericycle, Inc. (NASDAQ:SRCL) has received an average rating of “Hold” from the five analysts that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $59.40.

Several research analysts recently weighed in on SRCL shares. Royal Bank of Canada reiterated an “outperform” rating and set a $69.00 price target on shares of Stericycle in a research report on Thursday, March 7th. Stifel Nicolaus lifted their price target on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 29th. StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research report on Tuesday, April 2nd. Wells Fargo & Company boosted their price objective on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research report on Friday, March 1st. Finally, Robert W. Baird cut their price objective on Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research report on Friday, April 26th.

Stericycle Trading Down 0.4 %

Shares of NASDAQ:SRCL opened at $44.75 on Tuesday. Stericycle has a 52-week low of $37.78 and a 52-week high of $57.06. The stock has a market cap of $4.15 billion, a price-to-earnings ratio of -203.41, a PEG ratio of 2.45 and a beta of 1.12. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The business has a 50-day moving average price of $49.12 and a 200-day moving average price of $48.77.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company’s revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period last year, the business posted $0.49 earnings per share. Equities analysts predict that Stericycle will post 2.32 EPS for the current year.

Institutional Trading of Stericycle

Institutional investors have recently made changes to their positions in the company. Barclays PLC boosted its stake in shares of Stericycle by 30.6% in the third quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock worth $3,147,000 after acquiring an additional 16,505 shares during the last quarter. Earnest Partners LLC boosted its stake in shares of Stericycle by 6.6% in the third quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock worth $86,793,000 after acquiring an additional 120,852 shares during the last quarter. Pathstone Family Office LLC acquired a new stake in shares of Stericycle in the third quarter worth approximately $230,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Stericycle by 25.7% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 67,860 shares of the business services provider’s stock worth $3,034,000 after buying an additional 13,860 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Stericycle by 2.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,084,459 shares of the business services provider’s stock worth $53,746,000 after buying an additional 26,065 shares during the last quarter. 98.82% of the stock is owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.